ENCELTO
Live / Applied — Second extension granted (statement of use) (as of 25 Jun 2025)
What this means for you
Not registered yet, but its 04 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97741367
- Mark type
- Stylized text
- Filed
- 04 Jan 2023
- Published for opposition
- 30 Apr 2024
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Intravitreal implants, namely, implantable drug delivery devices sold filled with a pharmaceutical for the treatment of eye and vision conditions
- Class 010 — Medical apparatus: Medical device, namely, intraocular implant
Owner
- Neurotech Pharmaceuticals, Inc., Cumberland, RI, US
- Neurotech Pharmaceuticals, Inc., Cumberland, RI, US
Prosecution history
- 07 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 26 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jun 2025 — SOU EXTENSION 2 GRANTED
- 25 Jun 2025 — SOU EXTENSION 2 FILED
- 25 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2024 — SOU EXTENSION 1 GRANTED
- 12 Dec 2024 — SOU EXTENSION 1 FILED
- 12 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Apr 2024 — PUBLISHED FOR OPPOSITION
- 10 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED